Animol Discovery, Inc.
Biotechnology Research
201 Washington St.
15 employees
- Employees
- 15
- Contacts
- 4
- Emails
- 4
- Phones
- 2
Animol Discovery, Inc. Overview
- Headquarters
- 201 Washington St.
- Website
- animol-discovery.com
- Industry
- Biotechnology Research
- Employees
- 15
- Founded
- 2019
- Funding
- 4.0M
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
About Animol Discovery, Inc.
Animol is a drug discovery company that leverages the powerful combination of machine learning and DNA-encoded chemical libraries to build a proprietary pipeline of highly innovative pharmaceuticals for veterinary patients.
Animol Discovery, Inc. Contact Details
- People in AeroLeads
- 4
- With contact data
- 4
- Email contacts
- 4
- 100.0% coverage
- Phone contacts
- 2
- 50.0% coverage
Animol Discovery, Inc. Org Chart
Sample employees and titles| Name | Title | Location | Contact |
|---|---|---|---|
| David T. Stanton, Ph.d. | Head of Computational Chemistry | Boston, Massachusetts, United States |
Email
|
| Devin Leake | Managing Director at Novalis | Boston, Massachusetts, United States |
Email
Phone
|
| Brett Chevalier | Chief Scientist, Company Builder | Cambridge, Massachusetts, United States |
Email
Phone
|
| Nigel Walshe | Member of Scientific Advisory Board | Canterbury, England, United Kingdom |
Email
|
Employees by Management Level
Executive
1 profile
VP / Head
1 profile
Director
1 profile
Individual contributor
1 profile
Compare Similar Companies to Animol Discovery, Inc.
Monsanto Company
Farming
Roivant
Biotechnology
X-Chem, Inc.
Biotechnology Research
Terray Therapeutics
Biotechnology Research
Iveric Bio, An Astellas Company
Biotechnology Research
Enko®
Biotechnology Research
Orogen Therapeutics
Biotechnology Research
Invetx - a Dechra Division
Biotechnology Research
Anagenex
Biotechnology
HarkerBIO
Biotechnology Research